# Penn Scientists Develop Gene Therapy That Relieves Pain Without Opioid Addiction Risk

*2026-03-29 17:01 UTC · Science · 1 min read*

> Penn researchers publish first brain-targeted gene therapy for pain in Nature, offering opioid-level relief without addiction risk.

Researchers at the University of Pennsylvania have created a gene therapy that acts as a precise "off switch" for chronic pain in the brain, without triggering the addictive reward pathways that make opioids so dangerous. Published in Nature on March 28, the therapy uses AI-driven behavioral tracking to map how pain is processed in cortical circuits, then delivers a targeted intervention that mimics morphine's analgesic benefits while skipping its side effects.

Lead researcher Gregory Corder, assistant professor of psychiatry and neuroscience at Penn, called it "the world's first CNS-targeted gene therapy for pain and a concrete blueprint for non-addictive, circuit-specific pain medicine." The six-year project, funded by an NIH New Innovator Award, involved collaborators from Carnegie Mellon University and Stanford University.

The breakthrough addresses a massive public health crisis: over 50 million Americans live with chronic pain, costing more than $635 billion annually, while opioids were involved in 80% of 600,000 drug-related deaths in 2019 alone.

## Sources

- [nature.com](https://www.nature.com/articles/s41586-025-09908-w)
- [pennmedicine.org](https://www.pennmedicine.org/news/gene-therapy-switch-may-offer-non-addictive-pain-relief)
- [sciencedaily.com](https://www.sciencedaily.com/releases/2026/03/260328043558.htm)

---
TechTools News · https://techtools.cz/tools/news/article/1137-penn-scientists-develop-gene-therapy-that-relieves-pain-without-opioid
Česká verze: https://techtools.cz/tools/news/clanek/1184-vedci-z-pensylvanie-vyvinuli-genovou-terapii-ktera-tisi-bolest-bez-rizika
